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Objective: Post-traumatic osteoarthritis (PTOA) occurs after anterior cruciate ligament (ACL) injury. PTOA
may be initiated by early expression of proteolytic enzymes capable of causing degradation of the
articular cartilage at time of injury. This study investigated the production of three of these key proteases
in multiple joint tissues after ACL injury and subsequent markers of cartilage turnover.
Methods: ACL transection was performed in adolescent minipigs. Collagenase (MMP-1 and MMP-13) and
aggrecanase (ADAMTS-4) gene expression changes were quantiﬁed in the articular cartilage, synovium,
injured ligament, and the provisional scaffold at days 1, 5, 9, and 14 post-injury. Markers of collagen
degradation (C2C), synthesis (CPII) and aggrecan synthesis (CS 846) were quantiﬁed in the serum and
synovial ﬂuid. Histologic assessment of the cartilage integrity (OARSI scoring) was also performed.
Results: MMP-1 gene expression was upregulated in the articular cartilage, synovium and ligament after
ACL injury. MMP-13 expression was suppressed in the articular cartilage, but upregulated 100-fold in the
synovium and ligament. ADAMTS-4 was upregulated in the synovium and ligament but not in the
articular cartilage. The concentration of collagen degradation fragments (C2C) in the synovial joint ﬂuid
nearly doubled in the ﬁrst ﬁve days after injury.
Conclusion: We conclude that upregulation of genes coding for proteins capable of degrading cartilage
ECM is seen within the ﬁrst few days after ACL injury, and this response is seen not only in chondrocytes,
but also in cells in the synovium, ligament and provisional scaffold.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Post-traumatic osteoarthritis (PTOA) develops in more than 50%
of individuals who tear their anterior cruciate ligament (ACL)
within 10e20 years1. Recent work has shown that patients begin to
lose the proteoglycan and collagen molecules from cartilage in the
ﬁrst few weeks after injury, losses that are typically irrecover-
able2,3. In this study, we employed a large animal model to study
changes in gene and protein expression within the cartilage and
surrounding tissues as well as cartilage degradationwithin the ﬁrst
2 weeks following an induced ACL injury. There aremultiple tissues
which are in contact with the articular cartilage via the synovial
ﬂuid and thus could inﬂuence the response of the cartilage toC.M. Haslauer, Department of
Enders 270, 300 Longwood
edu (C.M. Haslauer).
s Research Society International. Pinjury. These tissues include the synovium, the ACL, and the pro-
visional scaffold.
Organized connective tissueswhichhave a net anabolic response
to injury and go on to heal do so in an orderly and predictable
fashion. The ﬁrst major step in that process is the formation of a
provisional scaffoldwithin thewound site that ﬁlls the gap between
the two damaged ends of the ligament. The trigger for scaffold for-
mation is thought to be the contact of blood with the exposed
collagen of the wound edges. This contact starts a cascade of pro-
cesses which result in the release of anabolic cytokines, including
ﬁbroblast growth factor 2 (FGF-2), vascular endothelial growth
factor (VEGF), platelet-derived growth factor (PDGF)-A and -B and
others, and wound healing progresses in an orderly and reliable
fashion4. However, after the ACL tears, it does not heal thewayother
ligaments do, even with suture repair. Recently, a mechanism has
beenproposed for this failure, namely thatwhen theACL tears inside
the knee joint, the contact of bloodwith the newly exposed collagen
results in formation of a provisional scaffold onlyover the torn edges
of the tissue, while the joint ﬂuid prevents formation of a bridgingublished by Elsevier Ltd. All rights reserved.
Table I
Sequences of porcine-speciﬁc qPCR primers
Gene Forward primer Reverse primer
GAPDH19 GGG CAT GAA CCA TGA GAA GT GTC TTC TGG GTG GCA GTG AT
MMP-1 CCA GAG AAG ATG TGG ACC
GTG CC
CCT GGG CCT GGC TGA AAA
GCA
MMP-13 CAC GCC TGA TTT GAC TCA TT CAT CAA AAT GGG CAT CTC CT
ADAMTS-420 CAG GGT CCC ATG TGC AAC GT CAT CTG CCA CCACCA GGG TCT
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tional provisional scaffold had any catabolic effect on the sur-
rounding cartilage of the knee joint after an ACL transection.
After injury, not only does the ACL fail to heal, but also the injury
leads to the development of PTOA of the knee joint in many pa-
tients. Matrix metalloproteinase-1 (MMP-1) and MMP-13 have
been found to play a role in the development of osteoarthritis
(OA)6,7. MMP-1 is responsible for breaking down interstitial colla-
gens, including types I, II, and III. MMP-13 is ﬁve to ten times more
active than MMP-1 in degrading collagen type II and is capable of
contributing to aggrecan degradation7,8. Therefore, it has been
suggested that MMP-13 may play an important role in articular
cartilage turnover and the pathophysiology associated with PTOA8.
The characteristic fragments generated from this collagenase ac-
tivity on type II collagen are quantiﬁable through ELISA (enzyme-
linked immunosorbent assay). The C2Cmarker identiﬁes fragments
following type II collagen cleavage by collagenases, includingMMP-
1 and MMP-139. The CPII marker, in contrast, is a marker of type II
procollagen synthesis10. Cartilage turnover is thus largely depen-
dent on the balance between collagen and aggrecan synthesis and
degradation.
In addition, aggrecanases are also thought to play a role in the
development of PTOA. A disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS-4) efﬁciently degrades aggre-
can11. This aggrecanase activity is balanced by aggrecan synthesis,
which also increases during the course of OA12. The chondroitin
sulfate 846 epitope (CS 846) has been examined as a marker of
aggrecan synthesis, with the greatest concentrations observed in
the synovial ﬂuid of OA patients with the longest disease duration
and greatest cartilage loss12,13.
Kraus et al. suggest that the early phase of acute injury provides
a window of opportunity to decrease the destructive joint pro-
cesses that may ultimately lead to the development of PTOA14. In
this study, we hypothesized that an isolated ACL injury prompts a
response in multiple tissues as early as 1 day after injury, which
results in changes in cytokine and protein expression over time.We
hypothesized that even in the absence of impact trauma to the
cartilage, ACL injury would produce a catabolic response in several
joint tissues (i.e., ligament, synovium, cartilage, provisional scaf-
fold). We further hypothesized that this upregulation of catabolic
genes would result in aggrecan and collagen destructionwithin the
cartilage within the ﬁrst 2 weeks of injury.
Materials and methods
Thirty adolescent Yucatan minipigs (Coyote CCI, Douglas, MA),
aged12e15months,were obtained for use in this study. Allminipigs
were handled according to approved Institutional Animal Care and
Use Committee (IACUC) protocols at Animal Resources at Children’s
Hospital (ARCH, Boston, MA). Minipigs were assigned to euthanasia
at one of four time points (day 1, 5, 9 or 14; n¼ 6 per group). Four of
the groupswere subjected to unilateral ACL transection, followed by
tissue harvest at the designated time point. A ﬁfth group of six non-
operated minipigs served as ACL-intact controls.
Surgical procedure
Twenty-four minipigs underwent unilateral ACL transection
as previously described5,15. Brieﬂy, the ACL of anesthetized ani-
mals were exposed by performing a medial arthrotomy and
partial resection of the fat pad. The ACL was then cut using a
scalpel blade at the junction of the proximal and middle thirds.
Functional loss of the ACL was veriﬁed using the Lachman ma-
neuver, a clinical exam used to assess the integrity of the ACL16.
The knee was closed in layers. Animals were allowed normalnutrition and ad lib activity following surgery throughout the
experimental period.
Tissue collection
At time of euthanasia, samples of cartilage, synovium, ACL and
the provisional scaffold (i.e., ACL scar tissue located between the
torn ends of the ligament) were harvested. Cartilage was harvested
from the weight-bearing surface of the femoral condyle and a
synovium sample was taken from the medial aspect of the joint at a
location remote from the arthrotomy site. Each tissue specimenwas
submerged in a cryovial containing RNAlater stabilization solution
(Ambion, Austin, TX, USA), then ﬂash frozen in liquid nitrogen and
stored at 80C until gene expression analysis. A second portion of
the cartilage tissue was embedded within Optimal Cutting Tem-
perature (OCT) medium (Sakura Finetek, CA, USA), frozen, and
stored at 80C for histological analysis. Systemic blood of control
animals was clotted to serve as a provisional scaffold control for the
intact group. Cartilage, intact ACL tissue, and synovium samples
were also harvested from the six unoperated animals.
The six minipigs euthanized at day 14 were also subjected to
serial serumand synovialﬂuiddraws. Serumand synovialﬂuidwere
sampledpre-transection, then at 5 and14days post-injurywhile the
subjects were under anesthesia. Blood was collected in serum
separator tubes, allowed to clot at room temperature, centrifuged at
1,000 g for 10min, and the serum aliquoted in 500 mL aliquots and
stored at 80C. Synovial ﬂuid was centrifuged at 3,000g for
10 min to remove any cells. The supernatant was removed and
stored in 120 mL aliquots in cryovials at 80C, with approximately
240e500 mL of synovial ﬂuid recovered at each time point.
Quantitative real-time PCR
The cartilage, ligament, synovium, and provisional scaffold
samples were examined for mRNA expression of several genes
using real-time reverse transcriptase polymerase chain reaction
(qPCR) run in duplicate. Brieﬂy, total RNA was extracted from the
frozen tissue using the PureLink RNA Mini Kit (Ambion, Austin, TX,
USA), treated with DNAse I (PureLink DNase, Invitrogen, Life
Technologies, NY, USA) according to the manufacturer’s protocol
and quantiﬁed. Total RNAwas reverse transcribed to generate cDNA
using the RETROscript kit (Ambion, Austin, TX, USA). Previously
reported primers were validated by sequencing the PCR product
and performing a basic local alignment search tool (BLAST) search
with these results. Primers are summarized in Table I. Sybr Green
PCR Mastermix (Applied Biosystems, Foster City, CA, USA) (10 mL),
nuclease-free water, forward and reverse primer (2 mL each), and
3 mL (cartilage) or 0.5 mL (ligament, synovium, provisional scaffold)
of the 1 mg cDNAweremixed and quantiﬁed in a reaction volume of
10 ml. No template controls were included to indicate contaminants
or non-speciﬁc ampliﬁcation. An Applied Biosystems 7900HT
(Applied Biosystems, Foster City, CA, USA) was used for ampliﬁca-
tion and detection. The PCR proﬁle conditions were 50C for 2 min,
95C for 10min, followed by 40 cycles of 95C for 15 s, 50C for 45 s,
and 60C for 45 s. Levels of gene expressionwere normalized to the
housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase
Fig. 1. Median fold change in MMP-1 (A), MMP-13 (B), and ADAMTS-4 (C) gene
expression levels in cartilage, synovium, ligament, and provisional scaffold in the
initial 2 weeks following ACL injuries compared to uninjured controls (Day 0). Note the
log 10 scale on the y-axis. Asterisks indicate signiﬁcant differences at P < 0.05 from
baseline (tissue from uninjured controls) within each tissue type for the six minipigs.
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ing the 2DDCt method17.
Collagen and aggrecan fragment detection by ELISA
Synovial ﬂuid and serum C2C, CPII, CS 846 levels were deter-
mined using commercially-available ELISA kits (60-1001-001, 60-
1004, and 60-1003-01; IBEX Pharmaceuticals Inc, Montreal, Can-
ada) as previously described for porcine tissue18e20. The IBEX C2C
sequence and porcine proteome have a 100% maximum identity
between the assay and porcine collagen alpha-1 (II) sequence.
Spiking studies were performed to document adequate antigen
retrieval for the porcine synovial ﬂuid. Synovial ﬂuid samples were
digested using 75 units/mL recombinant Streptomyces hyaluroni-
dase (Sigma Aldrich, USA) for 10 min at 37C prior to ELISA testing.
Safranin-O, active caspase 3, and chondroitin-6-sulfate
immunostaining in porcine cartilage specimens
Frozen section slides of porcine cartilage specimens from control
(non-injured) joints (n¼ 2) and day 14 post-ACL transection (n¼ 5)
knees were stained with Safranin-O and Fast Green. All sections
were evaluated for histologic signs of cartilage degeneration using a
modiﬁed Osteoarthritis Research Society International (OARSI)
scoring system inwhich two investigators blinded to the treatment
independently graded the best stained sections and arrived at a
consensus score as previously described21,22. Active caspase 3
staining was performed using rabbit polyclonal primary antibody
(Cat#ab13847, Abcam, Cambridge,MA) at 1:50 dilution overnight at
4C and a goat anti-rabbit secondary antibody (Life Technologies,
Molecular Probes) at 1:50 dilution. Vectashield mounting medium
with DAPI (Vector Laboratories Inc., Burlingame, CA) was used.
Frozen sections were incubated in 1% hydrogen peroxide in meth-
anol for 20min to block endogenous peroxidase activity. Slideswere
washed in PBS then digested with 0.2 units/ml chondroitinase ABC
(Sigma Aldrich, St. Louis, MO) for 2 h at room temperature. Slides
were blocked with 3% normal horse serum for 60 min at room
temperature and primary antibody incubation with chondroitin-6-
sulfate (MK 302, abcam, Cambridge, MA) was performed over-
night at 4C at a 1:100 dilution. The specimenswere then incubated
with biotinylated goat anti-mouse IgG in horse serum for 90 min
followed by avidin-horse radish peroxidase complex for 60min and
then 3,30-diaminobenzidine (DAB) for 5 min. Slides were counter-
stained with methyl green, dehydrated and mounted.
Statistical analyses
Gene expression was summarized as median (25th percentile,
75th percentile). Overall differences in gene expression levels were
assessed using KruskaleWallis H Test followed by post-hocManne
Whitney U Tests (SAS Version 9.2, SAS Institute Inc., Cary, NC). Sy-
novial ﬂuid and serum levels of cartilage biomarkers were reported
as median (25th percentile, 75th percentile). Comparisons were
determined using a Wilcoxon signed-rank test (R Statistical Soft-
ware; http://www.r-project.org/)23. P < 0.05 was considered sta-
tistically signiﬁcant for both gene expression and cartilage
biomarker analyses.
Results
MMP-1 gene expression changes in cartilage, synovium, ligament,
and provisional scaffold over 14 days following ACL injury
MMP-1 gene expression in the articular cartilage increased
signiﬁcantly by 16-fold compared to baseline levels by day 1(P¼ 0.0162) and remained moderately elevated at day 14, although
this difference was not signiﬁcant (P ¼ 0.0751) [Fig. 1(A)]. MMP-1
gene expression was signiﬁcantly upregulated by at least 9-fold at
day 14 in the synovium (P ¼ 0.0123) and 3-fold in the ligament
(P ¼ 0.0162), compared to baseline levels within each tissue. MMP-
1 gene expression was at least 9-fold higher than baseline at all
time points in the provisional scaffold; however, this change was
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respectively).
MMP-13 gene expression changes in cartilage, synovium, ligament,
and provisional scaffold over 14 days following ACL injury
MMP-13 gene expression in the articular cartilage was found to
be suppressed by 16-fold at day 1, increasing to over 200-fold by
day 5, a change that was statistically signiﬁcant [P ¼ 0.0312;
Fig. 1(B)]. In contrast, in the synovium, a 350-fold increase in MMP-
13 gene expression was seen by day 5, and remained that elevated
at day 14 (P ¼ 0.0123 for comparison to baseline for both time
points). Changes in the ligament were similar to those seen in the
synovium, with a 500-fold increase in MMP-13 gene expression
relative to baseline by ﬁve days after injury (P ¼ 0.0123), and
remained upregulated by at least 1,000-fold at days 9 and 14
(P ¼ 0.0123 and 0.0162, respectively). In the provisional scaffold, a
signiﬁcant 80-fold increase in MMP-13 expressionwas seen at both
days 9 and 14 (P ¼ 0.0342 and 0.0255, respectively).
ADAMTS-4 gene expression changes in the cartilage, synovium,
ligament, and provisional scaffold over 14 days following injury
ADAMTS-4 gene expression in the articular cartilage did not
change signiﬁcantly over the 2-week experiment [Fig. 1(C)]. In the
synovium, a 3-fold increase in ADAMTS-4 gene expression was
observed from days 1 to 14 (P ¼ 0.0162, 0.0123, 0.0123, and 0.0123,
respectively). In the ligament, a signiﬁcant 2-fold upregulation of
gene expression was seen by day 5, and persisted throughout the
remainder of the experiment (P ¼ 0.0123, 0.0123, 0.0162, respec-
tively). In the provisional scaffold, a signiﬁcant upregulation of 40-
fold was seen on the ﬁrst day after injury, and persisted throughout
the entire experiment (P ¼ 0.0255, 0.0481, 0.0342, 0.0255,
respectively).
Quantiﬁcation of aggrecan and collagen fragments in synovial ﬂuid
and serum
The synovial ﬂuid C2C levels increased by a factor of 1.5 in the
ﬁrst 5 days after injury and remained elevated at 14 days after
injury, changes that were signiﬁcant at both time points (P ¼ 0.041
and 0.024, respectively; Fig. 2). CPII levels in the synovial ﬂuid did
not change over time (P ¼ 0.32 and 0.079); nor did the C2C:CPII
ratios (P ¼ 0.54 and 0.25). The synovial ﬂuid CS 846 levels were
3,600 ng/mL at baseline and over 10,000 ng/mL at day 14; however,
this change was not statistically signiﬁcant (P ¼ 0.10). Spiking
studies for C2C, CPII and CS846 resulted in a 97%, 93% and 86%
recovery of the protein respectively from the synovial ﬂuid. This
recovery rate is consistent with prior reports of the use of the IBEX
ELISA kit for analysis of synovial ﬂuid24e26.
The C2C, CPII and CS 846 levels in porcine sera are presented in
Fig. 3. There was no signiﬁcant increase in any of the serum bio-
markers in the ﬁrst 2 weeks following ACL injury.
Histological assessment of Safranin-O, apoptosis, and chondroitin-6-
sulfate
The articular cartilage in the uninjured control knees appeared
smooth [OARSI score of 1.0, Fig. 4(A)], increasing to an average
OARSI score of 1.8 [Fig. 4(B)], primarily due to an increase in surface
roughness of the articular cartilage rather than observation of
cellular changes or glycosaminoglycan loss. There was no observed
change in C-6-S, a marker for chondroitin sulfate, seen with
immunohistochemistry at the 2-week time point. While there was
no caspase 3 detected in the cartilage from intact knees [Fig. 4(E)],active caspase 3 was detected in the superﬁcial zone chondrocytes
at day 14 [Fig. 4(F)].
Discussion
Results from this study convey the potential importance of an
early intervention strategy following ACL injury to minimize
cartilage damage. MMP-1, MMP-13 and ADAMTS-4 gene expression
were upregulated in the joint as early as 1 day following isolated
ACL injury, and the amount of type II collagen fragments in the
synovial ﬂuid nearly doubled within 5 days. While MMP-13 and
ADAMTS-4 were not signiﬁcantly upregulated in the articular
cartilage, these genes were upregulated in the adjacent synovium,
transected ACL, and provisional scaffold formed at the injury site;
tissues which had the potential to inﬂuence cartilage degradation
by releasing these degradative enzymes into the synovial ﬂuid. The
signiﬁcant increase in collagen degradation fragment concentra-
tions in the synovial ﬂuid within the ﬁrst 2 weeks after injury
suggest that this acute phase may be suited for interventions to
prevent cartilage loss after ACL injury.
Our results indicate that all of the joint tissues in this study
(articular cartilage, synovium, ligament and provisional scaffold)
are capable of upregulating MMP-1 expression following ACL
injury. This observed increased expression of MMP-1 in the artic-
ular cartilage is consistent with prior reports of MMP-1 gene
expression in cartilage of white rabbits subjected to ACL transec-
tion27 and in humans with OA28. In addition, the synovium and ACL
were found to upregulate their gene expression of MMP-13. This is
consistent with prior reports of a 28-fold increase in MMP-13 gene
expression in the injured ligament after 1 week in a rabbit ACL
transection model and an upregulation in both the ACL and syno-
vium in a rat ACL injurymodel after 1, 2, and 3 days29,30. In addition,
the lack of upregulation of MMP-13 in the articular cartilage is also
consistent with prior reports of a lack of MMP-13 upregulation in
the articular cartilage in the ﬁrst 7 days following destabilization of
the medial meniscus in a murine model31.
The upregulation of bothMMP-1 andMMP-13 expression by the
intra-articular tissues may be responsible for the increasing C2C
concentration in the synovial ﬂuid seen in the ﬁrst few days after
ACL injury. The increases in C2C concentration reported here are
similar to the increased levels previously reported at day 5 after
injury to the human knee3. While MMP-1 regulated cartilage
degradation may be due to the actions of chondrocytes as well as
synoviocytes and ﬁbroblasts, the MMP-13 regulated cartilage
degradation appears to be mediated by the synovium and injured
ligament, rather than the articular cartilage. As MMP-13 is thought
to be ﬁve to ten times more active in cleaving type II collagen than
MMP-1, it is likely that the synovium and ligament MMP-13 pro-
duction plays a key role in the early cartilage degradation seen after
ACL injury.
Aggrecan has been noted to be one of the ﬁrst cartilage extra-
cellular matrix proteins to undergo measurable loss after joint
injury, and thus is thought to be one of the early measures of
PTOA11,32. In this study, while we did not see increases in the gene
expression for ADAMTS-4 in the articular cartilage, we did see a 10-
and 3-fold increase in gene expression in the synovium and ACL,
respectively. These ﬁndings are consistent with those observed
after destabilization of the medial meniscus in the murine knee
joint, where ADAMTS-4 gene expression was noted to be elevated
at time points as early as 6 h after injury in whole joint prepara-
tions, following removal of the skin and muscle31. In addition to the
upregulation of ADAMTS-4, we also found a relative increase in
aggrecan synthesis fragments (CS 846) within the synovial ﬂuid at
day 14 post-injury, though this increase was not statistically sig-
niﬁcant (P ¼ 0.15 and 0.10 for day 5 and 14, respectively). An
Fig. 2. Synovial ﬂuid concentrations of C2C, CPII, C2C:CPII, and CS 846. The synovial ﬂuid aspirated from unoperated knees at Day 0 serves as the baseline control. Sample size
indicated in parentheses and asterisks indicate signiﬁcant differences from control at P < 0.05.
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prior reports of a similar increase found in human patients within
days after injury, peaking at 1 week32,33. The increased gene
expression for ADAMTS-4 observed in the synovium and transected
ACL and the associated production of aggrecanase synthesis frag-
ments suggests that the initiation of proteoglycan loss in the
articular cartilage after injury may be due to actions within tissues
other than the articular cartilage.
The provisional scaffold is thought to lead the repair of extra-
synovial ligaments, including the medial collateral ligament35.
However, in this study, the provisional scaffold that forms after an
intra-synovial ACL injury was found to serve a catabolic function as
well, with signiﬁcant upregulation of MMP-13 and ADAMTS-4. This
would suggest it is a catabolic mediator of similar or greater sig-
niﬁcance than the synovium and ligament. This is the ﬁrst report of
the catabolic components of the response of the native provisional
scaffold within the joint. This ﬁnding is consistent with what is
noted clinically, where patients with recurrent hemarthroses are
noted to prematurely develop cartilage loss36,37. Increased expres-
sions of MMPs have been observed in patients diagnosed with
pigmented villonodular synovitis, which has been suggested to
play a critical role in the cartilage destruction observed clinically37.
Osteochondral damage has also been detected via magnetic reso-
nance imaging in hemophiliac patients experiencing bleeding
within the joint36. This study suggests the provisional scaffold
formed after ACL injury may play a similar role in joint destruction,
ultimately leading to cartilage degradation.
In prior studies of PTOA after ACL injury, there has been much
debate over the root causeof this disease.While the impact damage is
typically in the lateral compartment, the resultingOA typically occurs
in themedial compartment, suggesting it is a “whole joint” response,rather than a site-speciﬁc response to local cartilage injury38. Cellular
apoptosis has previously been observed at both the impaction site as
well as adjacent, non-impacted areas34. Apoptosis was accompanied
by progressive cartilage degeneration, even at these non-impacted
sites. Additionally, delivery of a surfactant has been shown to delay
the expansion of cellular apoptosis, thereby protecting cartilage
integrity to a higher extent than inhibition of caspase 3 alone34. Re-
sults of this study suggest a post-traumatic hemarthrosis (which
routinely occurs after ACL injury) may thus be one of the factors that
initiate the catabolic reaction of the joint and the journey to PTOA.
Further studies to examine the role of the coagulation proteins and
blood degradation products on cartilage metabolism may shed new
light on the mechanism of PTOA development.
There are several limitations for this study. First, an animal
model was required in order to harvest the tissue and to evaluate
the changes over time. The porcinemodel was chosen in part due to
its large size, which is larger and easier to access surgically (i.e.,
more typical to that seen for humans) in comparison to smaller
animal models. The porcine model was also chosen because of
similarities in gait biomechanics and dependence on the ACL39e42.
However, it is possible that the timing of cytokine release and
protease activity would be different in humans. Secondly, this study
was performed with only a 2-week follow-up period. While this
was long enough to accomplish the initial goals of the study e
namely to determine the acute changes in the joint tissues after ACL
injury e it was not long enough to see macroscopic cartilage
breakdown. Finally, the joint is a complex structure comprised of
multiple tissue types. Though we have performed qPCR analysis on
several of these tissues, it is likely that each secretes proteins and
other signaling molecules into the synovial ﬂuid, which subse-
quently interact with the other tissues.
Fig. 3. Serum concentrations of C2C, CPII, C2C:CPII, and CS 846. The synovial ﬂuid aspirated from unoperated knees at Day 0 serves as the baseline control. No statistical differences
were found across days (n ¼ 6 per analysis).
Fig. 4. Representative Safranin-O/Fast Green (A, B) and active caspase 3 (E,F) immu-
nostaining in porcine cartilage from control (day 0 e A, C, E) and from day 14 (B, D, F)
post-ACL transection. Day 14 cartilage specimens exhibited slightly rougher cartilage
surface (shown by arrows). Active caspase 3 staining (red, shown by arrows) was
detected in cartilage specimens at days 0 and 14.
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whether or not they have an ACL reconstruction43. In this study, we
determined that gene expression of a keymatrix metalloproteinase
and aggrecanase were upregulated in the adjacent joint synovium,
transected ACL, and provisional scaffold, but not in the articular
cartilage. Collagen fragments in the synovial ﬂuid were increased at
only 5 days after injury, but the histologic changes appear to lag
behind, with only minor changes in surface roughness seen even at
2 weeks after injury. These ﬁnding suggest that cartilage changes
seen after ACL injury, even without impact trauma, may be medi-
ated not just by chondrocytes, but also by other tissues of the joint,
and thus the joint should be considered a complex organ with an
orchestrated response to injury, rather than a set of individual
tissues. These various joint tissues share the same synovial ﬂuid
environment, which makes determining which tissue is the key
player in cartilage degradation a challenge. However, the upregu-
lation of catabolic factors seen in the torn ligament, synovium,
provisional scaffold and articular cartilage after ACL injury suggests
the response of these tissues should be considered when studying
mechanisms of PTOA development after an ACL injury.
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